announced acquisition of additional Lochend Cardium
assets having production capability of around 650 boe/d, weighted 95 percent to light oil.
SAN DIEGO -- Cardium
Therapeutics (AMEX:CXM) and its subsidiary InnerCool Therapies today announced the completion of a $5 million commercial credit facility with Life Sciences Capital to support the launch of InnerCool's new product lines for patient temperature modulation and other ongoing product development activities.
SAN DIEGO, May 22, 2014 /PRNewswire/ -- Taxus Cardium
Pharmaceuticals Group Inc.
SAN DIEGO, March 17, 2014 /PRNewswire/ -- Cardium
SAN DIEGO, March 3, 2014 /PRNewswire/ -- Cardium
24, 2014 /PRNewswire/ -- As previously reported, Cardium
Therapeutics, an advanced regenerative therapeutics company, today announced that its common stock will begin trading on the OTCQB Marketplace under the ticker symbol "CRXM" commencing on Friday, January 24, 2014.
Health and AirLogix formally announce the coming together and "mixing" of their two organizations to create a single, integrated company that will bring innovative thinking and expanded capabilities to the healthcare market.
4, 2013 /PRNewswire/ -- Cardium
Therapeutics (NYSE MKT: CXM) today announced that Cardium
's Excellagen, a wound care product indicated for the treatment of hard to heal wounds such as diabetic foot ulcers and pressure ulcers as well as other dermal wounds, has been assigned a new and unique, Level II HCPCS (Health Care Common Procedure Coding System) product reimbursement code, Q4149.
18, 2013 /PRNewswire/ -- Cardium
Therapeutics (NYSE MKT: CXM) today announced that Cell-nique Corporation, which owns a variety of innovative businesses that are part of the Healthy Brands Collective, has acquired To Go Brands in an asset purchase for approximately $2.
SAN DIEGO -- Cardium
Therapeutics (AMEX:CXM) announced today that its Board of Directors elected Andrew M.
has four private company business units in its medical opportunities portfolio: (1) LifeAgain[sup.
If declared effective by the SEC, the shelf would enable Cardium
to raise funds from the offering through underwriters, agents, dealers or by sales directly to purchasers, subject to market conditions and the Company's capital needs.